Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia.
Preston NgoDeme KarikiosDavid GoldsburyStephen WadeZarnie LwinBrett G M HughesKwun M FongKaren CanfellMarianne WeberPublished in: PharmacoEconomics (2023)
Survival improvements for advanced lung cancer have been accompanied by growing treatment costs. The estimates reported here can be used for budget planning and economic evaluations of interventions across the spectrum of cancer control.